Ethics FORUM
Elizabeth A. Kitsis, MD, MBE, Michele Meltzer, MD, MBE, and C. Ronald MacKenzie, MD | Issue: January 2011 |
Related Articles
TNF Blockade for SLE
Reckless approach versus missed opportunity?
Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis
Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and small molecule inhibitor drugs…
Reading Rheum
Handpicked Reviews of Contemporary Literature
Ethics Forum: Is a Conflict-of-Interest Slide Enough?
We have all been to numerous lectures, grand rounds and other continuing medical education activities where the speaker, prepared and poised at the podium, begins his lecture with a title slide. Soon after, we see the ubiquitous conflicts of interest slide, which lists the invited speaker’s research funding, his consulting activities and his board memberships—all…